CN114317476B - Biocatalysis production process of glucosyl glycerine and sucrose phosphorylase thereof - Google Patents

Biocatalysis production process of glucosyl glycerine and sucrose phosphorylase thereof Download PDF

Info

Publication number
CN114317476B
CN114317476B CN202111653409.XA CN202111653409A CN114317476B CN 114317476 B CN114317476 B CN 114317476B CN 202111653409 A CN202111653409 A CN 202111653409A CN 114317476 B CN114317476 B CN 114317476B
Authority
CN
China
Prior art keywords
asp
leu
ala
sucrose
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202111653409.XA
Other languages
Chinese (zh)
Other versions
CN114317476A (en
Inventor
丁雪峰
李帅杰
刘珊珊
纪晓伟
王勇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Nuoyun Biotechnology Co ltd
Original Assignee
Nanjing Nuoyun Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Nuoyun Biotechnology Co ltd filed Critical Nanjing Nuoyun Biotechnology Co ltd
Priority to CN202111653409.XA priority Critical patent/CN114317476B/en
Publication of CN114317476A publication Critical patent/CN114317476A/en
Application granted granted Critical
Publication of CN114317476B publication Critical patent/CN114317476B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

The invention relates to the technical field of enzyme catalysis, in particular to a biocatalysis production process of glucosyl glycerine and sucrose phosphorylase thereof, wherein the amino acid sequence of the sucrose phosphorylase is shown as SEQ ID NO: 1. When the biocatalysis is used for producing the glucosyl glycerine, the sucrose mother liquor is taken, the buffer solution, the glycerine and the pure water are added, the crude enzyme solution of the sucrose phosphorylase is added for reaction at 37 ℃. Compared with wild sucrose phosphorylase, the sucrose phosphorylase in the biocatalysis production process has the advantages of higher reaction speed and higher activity, and can effectively shorten the reaction time, improve the production efficiency, reduce the energy consumption and comprehensively reduce the cost when the substrate is in high concentration.

Description

Biocatalysis production process of glucosyl glycerine and sucrose phosphorylase thereof
Technical Field
The invention relates to the technical field of enzyme catalysis, in particular to a biocatalysis production process of glucosyl glycerine and sucrose phosphorylase thereof.
Background
2-O- α -D-glucopyranosyl glycerol is mainly found in cyanobacteria for combating the osmotic pressure of saline-alkaline environments; it was also found to be present in plants Myrothamnus flabellifolia and to have the effect of reviving the plants. Such desert plants can survive many years of complete desiccation without losing tissue integrity. Glucosyl glycerols also have an important function of protecting cells and tissues (e.g. skin), which offers the potential for use in cosmetics. Since glucosyl glycoside has a high water binding capacity, it gives a strong moisturizing effect when applied to skin. In addition to cosmetic applications, glucosyl glycerols have great potential as low calorie sweeteners, which may have prebiotic effects.
It has been reported to be useful as a substitute sweetener in foods because of its low cariogenicity and caloric value compared to sucrose. In addition, glucosyl glycerols and derivatives thereof have been studied as therapeutic agents for diseases caused by protein misfolding and cancer treatment. In cosmetics, glucosyl glycerols are used as anti-aging agents and as moisture regulating compounds.
In order to support the development of industrial applications, glucosyl glycerols must be efficiently provided on a large scale. Microbial production of glucosyl glycerols may be limited by the output parameters achievable by biosynthesis. Specifically, in the engineering corynebacterium glutamicum, the concentration of the product is less than or equal to 2g/L, the yield and the productivity on the used substrate are low, and in the engineering cyanobacteria polycystic strain, the yield is even lower.
The existing preparation methods mainly comprise chemical synthesis methods, enzymatic in-vitro catalysis and biological synthesis methods. The chemical process may involve various starting compounds such as maltitol, isomaltose, trehalose, etc. The use of sodium periodate and sodium borohydride has been reported to catalyze maltitol to glucosyl glycerol, but at 18% yield. The yield of the method for catalyzing isomaltose by using acetic acid, lead tetraacetate and sodium borohydride is 12%. The yield is only 5% by taking trehalose as a raw material. And the byproducts have larger influence on the subsequent purification. Biosynthesis can be achieved by treatment of microorganisms such as stenotrophomonas (Stenotrophomonas rhizophila DSM 14405) or cyanobacteria by salt stress, which has the disadvantage of large-scale production difficulties.
Enzymatic catalysis mainly involves alpha-glucosidase, cyclodextrin glucanotransferase, glycosyl-glycerol-phosphate synthase and sucrose phosphorylase.
Among them, sucrose phosphorylase (EC2.4.1.7) is a specific transglycosidase. Mainly catalyzes two reactions: in the first category, the glucosyl group of glucose-1-phosphate may be transferred to a receptor. For example, glucose-1-phosphate and D-fructose are capable of producing sucrose under the catalysis of sucrose phosphorylase. Second, the glucosyl group in sucrose is transferred to the receptor. For example, sucrose and phosphoric acid are capable of producing glucose-1-phosphate and D-fructose under the catalysis of sucrose phosphorylase. In the absence of external influences, sucrose phosphorylase catalyzes the reversible conversion of sucrose and phosphate to glucose 1-phosphate and D-fructose. In the absence of phosphate, glycerol may intercept the glycosylase intermediate that reacts with sucrose to produce glycosylglycerol, with minimal hydrolysis side reactions occurring.
An efficient route for the preparation of glucosyl glycerols is sucrose phosphorylase. Sucrose is an excellent donor substrate for glycosylation of glycerol, has high yield (. Gtoreq.90%), and has good cost economy. Glucosyl glycerols are manufactured industrially by Bitop AG (dotmond, germany) using the biocatalytic process of lmSucp and formulated as commercial products for cosmetic applications, sold as Glycoin (50% solution of GG).
Leuconostoc mesenteroides-derived sucrose phosphorylase has a broad acceptor specificity when glucose-1-phosphate and sucrose are used as donors.
Bifidobacterium adolescentis sucrose phosphorylase uses only arabinose, arabitol and xylitol as acceptors when glucose-1-phosphate is used as glycosyl donor, and uses sucrose as glycosyl donor, the acceptors are wider and have higher activity.
Published patent WO2008034158 to the university of Gratz's technology is the first use of sucrose phosphorylase (SPase) to catalyze the conversion of sucrose and glycerol to glycerol glucoside at a concentration of about 0.29M for the glucosyl glycerol product at about 70g/L yield under reaction conditions of 0.3M sucrose and 2.0M glycerol. However, the method has the disadvantages of large enzyme dosage, low product concentration and the like.
The patent CN109576239A utilizes Thermoanaerobacterium thermosaccharolyticum source heat-resistant sucrose phosphorylase to carry out catalytic reaction under high temperature condition, avoids the decomposition of the substrate and the product by the enzyme and the growth of the bacteria, has the highest concentration of 189.8g/L and the highest conversion rate of 94 percent, and has better industrial production prospect. However, high conversions (60 g/L to 200g/L sucrose) are only obtained at low substrate concentrations, and the enzyme dosage is relatively high, in the case of a maximum concentration of 300g/L sucrose, the enzyme dosage is 150g/L, the mass ratio of substrate to enzyme is 2:1, the enzyme cost is relatively high, and the conversion rate of 28 hours of reaction under the condition is only 85.2 percent.
Disclosure of Invention
The invention aims to provide a biocatalysis production process of glucosyl glycerine and sucrose phosphorylase thereof.
In order to achieve the above purpose, the present invention provides the following technical solutions:
a sucrose phosphorylase, the amino acid sequence of which is shown in SEQ ID NO: 1.
The reaction speed of the sucrose phosphorylase is higher than that of the wild type sucrose phosphorylase. The conversion rate is more than 90 percent and is far higher than that of the wild type.
A biocatalysis production process of glucosyl glycerine specifically comprises the following steps: taking sucrose mother liquor, adding buffer solution, glycerol and pure water, adding the crude enzyme solution of the sucrose phosphorylase, and reacting at 37 ℃.
Experiments prove that the highest substrate concentration of the sucrose phosphorylase can reach 400g/L; and the conversion rate is greater than 90% in 3 hours.
The preparation method of the crude enzyme liquid comprises the following steps:
(1) By total gene synthesis, SEQ ID NO:1, and cloning the corresponding coding polynucleotide sequence of the protein shown in the formula 1 into a prokaryotic expression vector for expression so as to realize high expression in escherichia coli;
(2) Shaking flask fermentation
E.coli single colony containing the expression vector is selected and inoculated in 10mL of culture medium A after autoclaving, and is cultured at 30 ℃ and 250rpm overnight;
taking 1L triangular flask the next day, and mixing the materials according to the following weight ratio of 1:100 inoculation ratio example 100 is inoculated into 100mL of medium B after autoclaving, cultured at 30 ℃ until the cell OD 5-6 is reached, immediately placing the triangular flask in a 25 ℃ shaker, and culturing at 250rpm for 1 hour; IPTG was added to a final concentration of 0.1mM and incubation was continued at 25℃and 250rpm for 16 hours;
after the culture, the culture solution was centrifuged at 12000g for 20 minutes at 4℃to collect wet cells; then washing the bacterial precipitate twice with distilled water, collecting bacterial precipitate, and preserving at-70 ℃; simultaneously taking 2g of thalli, adding 6mL of pure water, performing SDS-PAGE detection after ultrasonic crushing, and preserving crude enzyme liquid at the temperature of minus 20 ℃;
(3) Fed-batch fermentation
Fed-batch fermentation was performed in a computer controlled bioreactor, with 200mL cultures prepared by primary inoculation of the strain, and inoculated at OD 2.0; the temperature was maintained at 37 ℃ throughout the fermentation, the dissolved oxygen concentration during the fermentation was automatically controlled at 30% by the stirring rate and aeration supply cascade, while the pH of the medium was maintained at 7.0 by 50% orthophosphoric acid and 30% aqueous ammonia;
during the fermentation, when the dissolved oxygen is greatly raised, feeding is started, and the feeding solution contains 9% w/v peptone, 9% w/v yeast extract and 14% w/v glycerol; when the OD600 was 35.0, induction was performed with 0.2mM IPTG for 16 hours; 2g of the cells were sonicated in 6mL of pure water, and then subjected to SDS-PAGE, and the crude enzyme solution was stored at-20 ℃.
Further, the medium a in the step (2) is: 10g/L of tryptone, 5g/L of yeast extract, 3.55g/L of disodium hydrogen phosphate, 3.4g/L of monopotassium phosphate, 2.68g/L of ammonium chloride, 0.71g/L of sodium sulfate, 0.493g/L of magnesium sulfate heptahydrate, 0.027g/L of ferric chloride hexahydrate, 5g/L of glycerol and 0.8g/L of glucose, and kanamycin is added to 50mg/L.
The culture medium B is as follows: 10g/L of tryptone, 5g/L of yeast extract, 3.55g/L of disodium hydrogen phosphate, 3.4g/L of monopotassium phosphate, 2.68g/L of ammonium chloride, 0.71g/L of sodium sulfate, 0.493g/L of magnesium sulfate heptahydrate, 0.027g/L of ferric chloride hexahydrate, 5g/L of glycerol and 0.3g/L of glucose, and kanamycin is added to 50mg/L.
Further, the culture medium used in the step (3) is: 24g/L of yeast extract, 12g/L of peptone, 0.4% of glucose, 2.31g/L of phosphatase and 12.54g/L of dipotassium hydrogen phosphate, and the pH value is 7.0.
Compared with the prior art, the invention has the beneficial effects that:
compared with wild sucrose phosphorylase, the sucrose phosphorylase has higher reaction speed and higher activity, and can effectively shorten the reaction time, improve the production efficiency, reduce the energy consumption and comprehensively reduce the cost in a high-concentration substrate.
The biocatalytic production process of the glucosyl glycerine has high conversion rate of more than 90 percent, is especially suitable for industrial mass production of the glucosyl glucoside, and can obtain better social benefit and economic value.
Drawings
FIG. 1 is a map of a substrate standard; sucrose for 10 minutes and glycerin for 16.8 minutes.
FIG. 2 shows the results of the test in example 2, wherein sucrose was used for 10 minutes, the target product was used for 11.7 minutes, fructose was used for 12.8 minutes, and glycerol was used for 16.8 minutes.
FIG. 3 shows the results of the comparative example, sucrose for 10 minutes, target product for 11.7 minutes, fructose for 12.8 minutes, and glycerin for 16.8 minutes.
FIG. 4 shows the results of the test in example 3, sucrose for 10 minutes, target product for 11.7 minutes, fructose for 12.8 minutes, and glycerol for 16.8 minutes
FIG. 5 shows the results of the test in example 4, sucrose for 10 minutes, the target product for 11.7 minutes, fructose for 12.8 minutes, and glycerin for 16.8 minutes.
Detailed Description
The following description of the embodiments of the present invention will be made clearly and completely with reference to the accompanying drawings, in which it is apparent that the embodiments described are only some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
The detection conditions referred to in the following examples are as follows.
Liquid phase detection conditions:
mobile phase: 5mM sulfuric acid
A detector: differential detector
Flow rate: 0.6mL/min
Column temperature: 50 DEG C
Differential detector cell temperature: 50 DEG C
250mm 4.6um femomei organic acid column was used.
EXAMPLE 1 preparation of crude enzyme solution
(1) By total gene synthesis, SEQ ID NO:1, and the corresponding coding polynucleotide sequence of the protein shown in SEQ ID NO:3 and cloning to prokaryotic expression vector for high expression in colibacillus, named ZY4.
Likewise, the control wild-type sucrose phosphorylase protein SEQ ID NO:2, the corresponding coding polynucleotide sequence SEQ ID NO:4, and cloning to prokaryotic expression vector for expression, named ZY3.
(2) Shaking flask fermentation
E.coli single colonies containing the expression vector were picked and inoculated into 10mL of autoclaved medium: 10g/L of tryptone, 5g/L of yeast extract, 3.55g/L of disodium hydrogen phosphate, 3.4g/L of monopotassium phosphate, 2.68g/L of ammonium chloride, 0.71g/L of sodium sulfate, 0.493g/L of magnesium sulfate heptahydrate, 0.027g/L of ferric chloride hexahydrate, 5g/L of glycerol and 0.8g/L of glucose, and kanamycin is added to 50mg/L. Culturing at 30℃and 250rpm overnight. Taking 1L triangular flask the next day, and mixing the materials according to the following weight ratio of 1: inoculation ratio of 100 example 100mL of autoclaved medium was inoculated: 10g/L of tryptone, 5g/L of yeast extract, 3.55g/L of disodium hydrogen phosphate, 3.4g/L of monopotassium phosphate, 2.68g/L of ammonium chloride, 0.71g/L of sodium sulfate, 0.493g/L of magnesium sulfate heptahydrate, 0.027g/L of ferric chloride hexahydrate, 5g/L of glycerol and 0.3g/L of glucose, and kanamycin is added to 50mg/L. The cells were cultured at 30℃until the cell OD 5-6 was reached, and the flask was immediately placed in a 25℃shaker at 250rpm for 1 hour. IPTG was added to a final concentration of 0.1mM and the incubation was continued at 25℃and 250rpm for 16 hours. After the completion of the culture, the culture was centrifuged at 12000g for 20 minutes at 4℃to collect wet cells. Then the bacterial cell precipitate is washed twice with distilled water, and the bacterial cells are collected and stored at-70 ℃. Meanwhile, 2g of thalli are added with 6mL of pure water for ultrasonic crushing, SDS-PAGE detection is carried out, and crude enzyme liquid is preserved at the temperature of minus 20 ℃.
(3) Fed-batch fermentation:
fed-batch fermentation was carried out in a computer-controlled bioreactor (Shanghai state of China) with a capacity of 15L and a working volume of 8L, using 24g/L yeast extract, 12g/L peptone, 0.4% glucose, 2.31g/L dihydrogenphosphate and 12.54g/L dipotassium hydrogen phosphate, pH 7.0. 200mL cultures were prepared from the primary seed strain and inoculated at OD 2.0. The temperature was maintained at 37℃throughout the fermentation, the dissolved oxygen concentration was automatically controlled at 30% by a stirring rate (rpm) and aeration supply cascade, and the pH of the medium was maintained at 7.0 by 50% (v/v) orthophosphoric acid and 30% (v/v) aqueous ammonia. During the fermentation process, when the dissolved oxygen is greatly raised, the feeding is started. The feed solution contained 9% w/v peptone, 9% w/v yeast extract, 14% w/v glycerol. When the OD600 was about 35.0 (wet weight about 60 g/L), induction was performed with 0.2mM IPTG for 16 hours. 2g of the cells were sonicated in 6mL of pure water, and then subjected to SDS-PAGE, and the crude enzyme solution was stored at-20 ℃.
Example 2 catalytic reaction application example
Firstly, preparing sucrose mother liquor (800 g/L), taking 800g of sucrose, adding water to a constant volume to 1L, and heating to aid dissolution for later use.
2ml of the total reaction system, 50mM MES pH7.0,0.9M sucrose with final concentration and 1.8M glycerol are prepared in a 5ml centrifuge tube, water is added to 1.8ml, pH is adjusted to 7, and then 0.2ml of new enzyme preparation ZY4 is added for shaking table reaction at 37 ℃. Sampling and detecting for 3 hours. The HPLC results are shown in FIG. 2. Sucrose 3 hours conversion was greater than 97% at glycerol excess.
Comparative example control of catalytic reactions
2ml of the total reaction system, 50mM MES pH7.0,0.9M sucrose with final concentration, 1.8M glycerol and 1.8ml of water are prepared in a 5ml centrifuge tube, pH is adjusted to 7, and then 0.2ml of new enzyme preparation ZY3 is added for shaking table reaction at 37 ℃. Sampling and detecting for 3 hours. The HPLC results are shown in FIG. 3. Sucrose 3 hours conversion was only 72% at glycerol excess.
Example 3 high concentration catalytic reaction example
Firstly, preparing sucrose mother liquor (800 g/L), taking 800g of sucrose, adding water to a constant volume to 1L, and heating to aid dissolution for later use.
2ml of the total reaction system, 50mM MES pH7.0,1.2M sucrose (reduced to 408g/L substrate concentration), 1.8M glycerol, water addition to 1.8ml, pH adjustment to 7, and addition of 0.2ml of fresh enzyme solution ZY4, and shaking reaction at 37 ℃. Sampling and detecting for 3 hours. Because of the high substrate concentration, the sample is diluted 20 times with pure water before injection. The HPLC results are shown in FIG. 4. Sucrose 3 hours conversion was greater than 90% at glycerol excess.
Example 4 high concentration catalytic reaction example
Firstly, preparing sucrose mother liquor (800 g/L), taking 800g of sucrose, adding water to a constant volume to 1L, and heating to aid dissolution for later use.
2ml of the total reaction system, 50mM MES pH7.0,0.9M sucrose (reduced to 306g/L substrate concentration), 1.8M glycerol, water addition to 1.8ml, pH adjustment to 7, and addition of 0.2ml of fresh enzyme solution ZY4, and shaking reaction at 37 ℃. Sampling and detecting for 3 hours. Because of the high substrate concentration, the sample is diluted 20 times with pure water before injection. The HPLC results are shown in FIG. 5. Sucrose 3 hours conversion was greater than 96%.
As can be seen from the comparison of the experimental results, the sucrose phosphorylase has a faster reaction speed than the wild sucrose phosphorylase, and can still effectively shorten the reaction time at high concentration of substrate, improve the production efficiency, reduce the energy consumption and comprehensively reduce the cost; the reaction system has high conversion rate and high reaction speed, can still keep the conversion rate of sucrose to be more than 90% in 3 hours reaction time when high-concentration sucrose reacts, and has no obvious byproducts except fructose. Is especially suitable for the industrial mass production of the glyceroglycosides, and can obtain better social benefit and economic value.
Although embodiments of the present invention have been shown and described, it will be understood by those skilled in the art that various changes, modifications, substitutions and alterations can be made therein without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Sequence listing
<110> Nanjing Nocloud biotechnology Co., ltd
<120> biocatalytic production process of glucosyl glycerol and sucrose phosphorylase thereof
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 504
<212> PRT
<213> Artificial sequence (Artificial Sequence)
<400> 1
Met Lys Asn Lys Val Gln Leu Ile Thr Tyr Ala Asp Arg Leu Gly Asp
1 5 10 15
Gly Thr Ile Lys Ser Met Thr Asp Ile Leu Arg Thr Arg Phe Asp Gly
20 25 30
Val Tyr Asp Gly Val His Ile Leu Pro Phe Phe Thr Pro Phe Asp Gly
35 40 45
Ala Asp Ala Gly Phe Asp Pro Ile Asp His Thr Lys Val Asp Glu Arg
50 55 60
Leu Gly Ser Trp Asp Asp Val Ala Glu Leu Ser Lys Thr His Asn Ile
65 70 75 80
Met Val Asp Ala Ile Val Asn His Met Ser Trp Glu Ser Lys Gln Phe
85 90 95
Gln Asp Val Leu Ala Lys Gly Glu Glu Ser Glu Tyr Tyr Pro Met Phe
100 105 110
Leu Thr Met Ser Ser Val Phe Pro Asn Gly Ala Thr Glu Glu Asp Leu
115 120 125
Ala Gly Ile Tyr Arg Pro Arg Pro Gly Leu Pro Phe Thr His Tyr Thr
130 135 140
Phe Ala Gly Lys Thr Arg Leu Val Trp Val Ser Phe Thr Pro Gln Gln
145 150 155 160
Val Asp Ile Asp Thr Asp Ser Asp Lys Gly Trp Glu Tyr Leu Met Ser
165 170 175
Ile Phe Asp Gln Met Ala Ala Ser His Val Ser Tyr Ile Arg Leu Asp
180 185 190
Ala Val Gly Tyr Gly Ala Lys Glu Ala Gly Thr Ser Cys Phe Met Thr
195 200 205
Pro Lys Thr Phe Lys Leu Ile Ser Arg Leu Arg Glu Glu Gly Val Lys
210 215 220
Arg Gly Leu Glu Ile Leu Ile Glu Val His Ser Tyr Tyr Lys Lys Gln
225 230 235 240
Val Glu Ile Ala Ser Lys Val Asp Arg Val Tyr Asp Phe Ala Leu Pro
245 250 255
Pro Leu Leu Leu His Ala Leu Ser Thr Gly His Val Glu Pro Val Ala
260 265 270
His Trp Thr Asp Ile Arg Pro Asn Asn Gln Val Thr Val Leu Asp Thr
275 280 285
His Asp Gly Ile Gly Val Ile Asp Ile Gly Ser Asp Gln Leu Asp Arg
290 295 300
Ser Leu Lys Gly Leu Val Pro Asp Glu Asp Val Asp Asn Leu Val Asn
305 310 315 320
Thr Ile His Ala Asn Thr His Gly Glu Ser Gln Ala Ala Thr Gly Ala
325 330 335
Ala Ala Ser Asn Leu Asp Leu Tyr Gln Val Asn Ser Thr Tyr Tyr Ser
340 345 350
Ala Leu Gly Cys Asn Asp Gln His Tyr Ile Ala Ala Arg Ala Val Gln
355 360 365
Phe Phe Leu Pro Gly Val Pro Gln Val Tyr Tyr Val Gly Ala Leu Ala
370 375 380
Gly Lys Asn Asp Met Glu Leu Leu Arg Lys Thr Asn Asn Gly Arg Asp
385 390 395 400
Ile Asn Arg His Tyr Tyr Ser Thr Ala Glu Ile Asp Glu Asn Leu Lys
405 410 415
Arg Pro Val Val Lys Ala Leu Asn Ala Leu Ala Lys Phe Arg Asn Glu
420 425 430
Leu Asp Ala Phe Asp Gly Thr Phe Ser Tyr Thr Thr Asp Asp Asp Thr
435 440 445
Ser Ile Ser Phe Thr Trp Arg Gly Glu Thr Ser Gln Ala Thr Leu Thr
450 455 460
Phe Glu Pro Lys Arg Gly Leu Gly Val Asp Asn Thr Thr Pro Val Ala
465 470 475 480
Met Leu Glu Trp Glu Asp Ser Ala Gly Asp His Arg Ser Asp Asp Leu
485 490 495
Ile Ala Asn Pro Pro Val Val Ala
500
<210> 2
<211> 504
<212> PRT
<213> Artificial sequence (Artificial Sequence)
<400> 2
Met Lys Asn Lys Val Gln Leu Ile Thr Tyr Ala Asp Arg Leu Gly Asp
1 5 10 15
Gly Thr Ile Lys Ser Met Thr Asp Ile Leu Arg Thr Arg Phe Asp Gly
20 25 30
Val Tyr Asp Gly Val His Ile Leu Pro Phe Phe Thr Pro Phe Asp Gly
35 40 45
Ala Asp Ala Gly Phe Asp Pro Ile Asp His Thr Lys Val Asp Glu Arg
50 55 60
Leu Gly Ser Trp Asp Asp Val Ala Glu Leu Ser Lys Thr His Asn Ile
65 70 75 80
Met Val Asp Ala Ile Val Asn His Met Ser Trp Glu Ser Lys Gln Phe
85 90 95
Gln Asp Val Leu Ala Lys Gly Glu Glu Ser Glu Tyr Tyr Pro Met Phe
100 105 110
Leu Thr Met Ser Ser Val Phe Pro Asn Gly Ala Thr Glu Glu Asp Leu
115 120 125
Ala Gly Ile Tyr Arg Pro Arg Pro Gly Leu Pro Phe Thr His Tyr Lys
130 135 140
Phe Ala Gly Lys Thr Arg Leu Val Trp Val Ser Phe Thr Pro Gln Gln
145 150 155 160
Val Asp Ile Asp Thr Asp Ser Asp Lys Gly Trp Glu Tyr Leu Met Ser
165 170 175
Ile Phe Asp Gln Met Ala Ala Ser His Val Ser Tyr Ile Arg Leu Asp
180 185 190
Ala Val Gly Tyr Gly Ala Lys Glu Ala Gly Thr Ser Cys Phe Met Thr
195 200 205
Pro Lys Thr Phe Lys Leu Ile Ser Arg Leu Arg Glu Glu Gly Val Lys
210 215 220
Arg Gly Leu Glu Ile Leu Ile Glu Val His Ser Tyr Tyr Lys Lys Gln
225 230 235 240
Val Glu Ile Ala Ser Lys Val Asp Arg Val Tyr Asp Phe Ala Leu Pro
245 250 255
Pro Leu Leu Leu His Ala Leu Ser Thr Gly His Val Glu Pro Val Ala
260 265 270
His Trp Thr Asp Ile Arg Pro Asn Asn Ala Val Thr Val Leu Asp Thr
275 280 285
His Asp Gly Ile Gly Val Ile Asp Ile Gly Ser Asp Gln Leu Asp Arg
290 295 300
Ser Leu Lys Gly Leu Val Pro Asp Glu Asp Val Asp Asn Leu Val Asn
305 310 315 320
Thr Ile His Ala Asn Thr His Gly Glu Ser Gln Ala Ala Thr Gly Ala
325 330 335
Ala Ala Ser Asn Leu Asp Leu Tyr Gln Val Asn Ser Thr Tyr Tyr Ser
340 345 350
Ala Leu Gly Cys Asn Asp Gln His Tyr Ile Ala Ala Arg Ala Val Gln
355 360 365
Phe Phe Leu Pro Gly Val Pro Gln Val Tyr Tyr Val Gly Ala Leu Ala
370 375 380
Gly Lys Asn Asp Met Glu Leu Leu Arg Lys Thr Asn Asn Gly Arg Asp
385 390 395 400
Ile Asn Arg His Tyr Tyr Ser Thr Ala Glu Ile Asp Glu Asn Leu Lys
405 410 415
Arg Pro Val Val Lys Ala Leu Asn Ala Leu Ala Lys Phe Arg Asn Glu
420 425 430
Leu Asp Ala Phe Asp Gly Thr Phe Ser Tyr Thr Thr Asp Asp Asp Thr
435 440 445
Ser Ile Ser Phe Thr Trp Arg Gly Glu Thr Ser Gln Ala Thr Leu Thr
450 455 460
Phe Glu Pro Lys Arg Gly Leu Gly Val Asp Asn Thr Thr Pro Val Ala
465 470 475 480
Met Leu Glu Trp Glu Asp Ser Ala Gly Asp His Arg Ser Asp Asp Leu
485 490 495
Ile Ala Asn Pro Pro Val Val Ala
500
<210> 3
<211> 1515
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 3
atgaaaaaca aagttcagct gatcacctac gctgaccgtc tgggtgacgg taccatcaaa 60
tctatgaccg acatcctgcg tacccgtttc gacggtgttt acgacggtgt tcacatcctg 120
ccgttcttca ccccgttcga cggtgctgac gctggtttcg acccgatcga ccacaccaaa 180
gttgacgaac gtctgggttc ttgggacgac gttgctgaac tgtctaaaac ccacaacatc 240
atggttgacg ctatcgttaa ccacatgtct tgggaatcta aacagttcca ggacgttctg 300
gctaaaggtg aagaatctga atactacccg atgttcctga ccatgtcttc tgttttcccg 360
aacggtgcta ccgaagaaga cctggctggt atctaccgtc cgcgtccggg tctgccgttc 420
acccactaca ccttcgctgg taaaacccgt ctggtttggg tttctttcac cccgcagcag 480
gttgacatcg acaccgactc tgacaaaggt tgggaatacc tgatgtctat cttcgaccag 540
atggctgctt ctcacgtttc ttacatccgt ctggacgctg ttggttacgg tgctaaagaa 600
gctggtacct cttgcttcat gaccccgaaa accttcaaac tgatctctcg tctgcgtgaa 660
gaaggtgtta aacgtggtct ggaaatcctg atcgaagttc actcttacta caaaaaacag 720
gttgaaatcg cttctaaagt tgaccgtgtt tacgacttcg ctctgccgcc gctgctgctg 780
cacgctctgt ctaccggtca cgttgaaccg gttgctcact ggaccgacat ccgtccgaac 840
aaccaggtta ccgttctgga cacccacgac ggtatcggtg ttatcgacat cggttctgac 900
cagctggacc gttctctgaa aggtctggtt ccggacgaag acgttgacaa cctggttaac 960
accatccacg ctaacaccca cggtgaatct caggctgcta ccggtgctgc tgcttctaac 1020
ctggacctgt accaggttaa ctctacctac tactctgctc tgggttgcaa cgaccagcac 1080
tacatcgctg ctcgtgctgt tcagttcttc ctgccgggtg ttccgcaggt ttactacgtt 1140
ggtgctctgg ctggtaaaaa cgacatggaa ctgctgcgta aaaccaacaa cggtcgtgac 1200
atcaaccgtc actactactc taccgctgaa atcgacgaaa acctgaaacg tccggttgtt 1260
aaagctctga acgctctggc taaattccgt aacgaactgg acgctttcga cggtaccttc 1320
tcttacacca ccgacgacga cacctctatc tctttcacct ggcgtggtga aacctctcag 1380
gctaccctga ccttcgaacc gaaacgtggt ctgggtgttg acaacaccac cccggttgct 1440
atgctggaat gggaagactc tgctggtgac caccgttctg acgacctgat cgctaacccg 1500
ccggttgttg cttaa 1515
<210> 4
<211> 1515
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 4
atgaaaaaca aagttcagct gatcacctac gctgaccgtc tgggtgacgg taccatcaaa 60
tctatgaccg acatcctgcg tacccgtttc gacggtgttt acgacggtgt tcacatcctg 120
ccgttcttca ccccgttcga cggtgctgac gctggtttcg acccgatcga ccacaccaaa 180
gttgacgaac gtctgggttc ttgggacgac gttgctgaac tgtctaaaac ccacaacatc 240
atggttgacg ctatcgttaa ccacatgtct tgggaatcta aacagttcca ggacgttctg 300
gctaaaggtg aagaatctga atactacccg atgttcctga ccatgtcttc tgttttcccg 360
aacggtgcta ccgaagaaga cctggctggt atctaccgtc cgcgtccggg tctgccgttc 420
acccactaca aattcgctgg taaaacccgt ctggtttggg tttctttcac cccgcagcag 480
gttgacatcg acaccgactc tgacaaaggt tgggaatacc tgatgtctat cttcgaccag 540
atggctgctt ctcacgtttc ttacatccgt ctggacgctg ttggttacgg tgctaaagaa 600
gctggtacct cttgcttcat gaccccgaaa accttcaaac tgatctctcg tctgcgtgaa 660
gaaggtgtta aacgtggtct ggaaatcctg atcgaagttc actcttacta caaaaaacag 720
gttgaaatcg cttctaaagt tgaccgtgtt tacgacttcg ctctgccgcc gctgctgctg 780
cacgctctgt ctaccggtca cgttgaaccg gttgctcact ggaccgacat ccgtccgaac 840
aacgctgtta ccgttctgga cacccacgac ggtatcggtg ttatcgacat cggttctgac 900
cagctggacc gttctctgaa aggtctggtt ccggacgaag acgttgacaa cctggttaac 960
accatccacg ctaacaccca cggtgaatct caggctgcta ccggtgctgc tgcttctaac 1020
ctggacctgt accaggttaa ctctacctac tactctgctc tgggttgcaa cgaccagcac 1080
tacatcgctg ctcgtgctgt tcagttcttc ctgccgggtg ttccgcaggt ttactacgtt 1140
ggtgctctgg ctggtaaaaa cgacatggaa ctgctgcgta aaaccaacaa cggtcgtgac 1200
atcaaccgtc actactactc taccgctgaa atcgacgaaa acctgaaacg tccggttgtt 1260
aaagctctga acgctctggc taaattccgt aacgaactgg acgctttcga cggtaccttc 1320
tcttacacca ccgacgacga cacctctatc tctttcacct ggcgtggtga aacctctcag 1380
gctaccctga ccttcgaacc gaaacgtggt ctgggtgttg acaacaccac cccggttgct 1440
atgctggaat gggaagactc tgctggtgac caccgttctg acgacctgat cgctaacccg 1500
ccggttgttg cttaa 1515

Claims (4)

1. A sucrose phosphorylase, characterized in that: the amino acid sequence is shown in SEQ ID NO: 1.
2. A biocatalytic production process of glucosyl glycerine is characterized in that: taking sucrose mother liquor, adding buffer solution, glycerol and pure water, adding crude enzyme solution containing sucrose phosphorylase as defined in claim 1, and reacting at 37 ℃; the amino acid sequence of the sucrose phosphorylase is shown as SEQ ID NO: 1.
3. The biocatalytic production process of glucosyl glycerol according to claim 2, wherein the preparation method of the crude enzyme solution comprises the following steps:
(1) By total gene synthesis, SEQ ID NO:1, and cloning the corresponding coding polynucleotide sequence of the protein shown in the formula 1 into a prokaryotic expression vector for expression so as to realize high expression in escherichia coli;
(2) Shaking and fermenting:
e.coli single colony containing the expression vector is selected and inoculated in 10mL of culture medium A after autoclaving, and is cultured at 30 ℃ and 250rpm overnight; the culture medium A is as follows: 10g/L of tryptone, 5g/L of yeast extract, 3.55g/L of disodium hydrogen phosphate, 3.4g/L of monopotassium phosphate, 2.68g/L of ammonium chloride, 0.71g/L of sodium sulfate, 0.493g/L of magnesium sulfate heptahydrate, 0.027g/L of ferric chloride hexahydrate, 5g/L of glycerol and 0.8g/L of glucose, and adding kanamycin to 50mg/L;
taking 1L triangular flask the next day, and mixing the materials according to the following weight ratio of 1: inoculating 100 to 100mL of autoclaved culture medium B, culturing at 30deg.C until the cell OD 5-6 is reached, immediately placing the triangular flask in 25 deg.C shaking table, and culturing at 250rpm for 1 hr; IPTG was added to a final concentration of 0.1mM and incubation was continued at 25℃and 250rpm for 16 hours; the culture medium B is as follows: 10g/L of tryptone, 5g/L of yeast extract, 3.55g/L of disodium hydrogen phosphate, 3.4g/L of monopotassium phosphate, 2.68g/L of ammonium chloride, 0.71g/L of sodium sulfate, 0.493g/L of magnesium sulfate heptahydrate, 0.027g/L of ferric chloride hexahydrate, 5g/L of glycerol and 0.3g/L of glucose, and adding kanamycin to 50mg/L;
after the culture, the culture solution was centrifuged at 12000g for 20 minutes at 4℃to collect wet cells; then washing the bacterial precipitate twice with distilled water, collecting bacterial precipitate, and preserving at-70 ℃; simultaneously taking 2g of thalli, adding 6mL of pure water, performing SDS-PAGE detection after ultrasonic crushing, and preserving crude enzyme liquid at the temperature of minus 20 ℃;
alternatively, fed-batch fermentation:
fed-batch fermentation is carried out in a computer-controlled bioreactor, 200mL of culture is prepared by primary inoculation strain, and is connected to the bioreactor when the culture is OD2.0, wherein the strain is escherichia coli containing the expression vector and prepared in the step (1); the temperature was maintained at 37℃throughout the fermentation, the dissolved oxygen concentration during the fermentation was automatically controlled at 30% by the stirring rate and aeration supply cascade, and the pH of the medium was maintained at 7.0 by 50% v/v orthophosphoric acid and 30% v/v aqueous ammonia;
during the fermentation, when the dissolved oxygen is greatly raised, feeding is started, and the feeding solution contains 9% w/v peptone, 9% w/v yeast extract and 14% w/v glycerol; when the OD600 was 35.0, induction was performed with 0.2mM IPTG for 16 hours; 2g of the cells were sonicated in 6mL of pure water, and then subjected to SDS-PAGE, and the crude enzyme solution was stored at-20 ℃.
4. A biocatalytic production process of glucosyl glycerol according to claim 3, characterized in that: the culture medium used for fed-batch fermentation in the step (2) of the crude enzyme preparation method is as follows: 24g/L of yeast extract, 12g/L of peptone, 0.4% w/v glucose, 2.31g/L of phosphatase and 12.54g/L of dipotassium hydrogen phosphate, pH 7.0.
CN202111653409.XA 2021-12-30 2021-12-30 Biocatalysis production process of glucosyl glycerine and sucrose phosphorylase thereof Active CN114317476B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111653409.XA CN114317476B (en) 2021-12-30 2021-12-30 Biocatalysis production process of glucosyl glycerine and sucrose phosphorylase thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111653409.XA CN114317476B (en) 2021-12-30 2021-12-30 Biocatalysis production process of glucosyl glycerine and sucrose phosphorylase thereof

Publications (2)

Publication Number Publication Date
CN114317476A CN114317476A (en) 2022-04-12
CN114317476B true CN114317476B (en) 2023-07-14

Family

ID=81019360

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111653409.XA Active CN114317476B (en) 2021-12-30 2021-12-30 Biocatalysis production process of glucosyl glycerine and sucrose phosphorylase thereof

Country Status (1)

Country Link
CN (1) CN114317476B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107058205A (en) * 2017-06-05 2017-08-18 江南大学 A kind of recombined bacillus subtilis for producing sucrose phosphorylase and its application
CN109423485A (en) * 2017-08-25 2019-03-05 中国科学院微生物研究所 Saccharose phosphorylation enzyme mutant and its application
CN109563493A (en) * 2016-06-15 2019-04-02 科德克希思公司 The enzymatic of steviol glycoside class and other compound glucose -1-phosphates glycosylates
CN113383072A (en) * 2018-10-29 2021-09-10 博努莫斯股份有限公司 Enzyme method for producing hexose

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5955314B2 (en) * 2010-04-06 2016-07-20 ウニベルズィタイト・ヘント Thermostable sucrose phosphorylase
WO2016075219A1 (en) * 2014-11-14 2016-05-19 Universiteit Gent A sucrose phosphorylase for the production of kojibiose

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109563493A (en) * 2016-06-15 2019-04-02 科德克希思公司 The enzymatic of steviol glycoside class and other compound glucose -1-phosphates glycosylates
CN107058205A (en) * 2017-06-05 2017-08-18 江南大学 A kind of recombined bacillus subtilis for producing sucrose phosphorylase and its application
CN109423485A (en) * 2017-08-25 2019-03-05 中国科学院微生物研究所 Saccharose phosphorylation enzyme mutant and its application
CN113383072A (en) * 2018-10-29 2021-09-10 博努莫斯股份有限公司 Enzyme method for producing hexose

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Increasing the thermostability of sucrose phosphorylase by a combination of sequence- and structure-based mutagenesis;An Cerdobbel等;《 Protein Eng Des Sel.》;第24卷(第11期);第829-834页 *
Structural Rearrangements of Sucrose Phosphorylase from Bifidobacterium adolescentis during Sucrose Conversion;Osman Mirza等;《THE JOURNAL OF BIOLOGICAL CHEMISTRY》;第281卷(第46期);第35576-35584页 *
sucrose phosphorylase [Bifidobacterium adolescentis];WP_011742626.1;《GenBank数据库》;参见序列部分 *
蔗糖磷酸化酶的研究进展;杨林莉等;《微生物学通报》;第48卷(第12期);第4904−4917页 *

Also Published As

Publication number Publication date
CN114317476A (en) 2022-04-12

Similar Documents

Publication Publication Date Title
CN111712570B (en) Engineering strain for producing psicose and derivatives thereof, construction method and application thereof
CN113122491B (en) Recombinant microorganism for producing N-acetylneuraminic acid and application thereof
CN113717910B (en) Tri-enzyme co-expression recombinant bacterium and application thereof in (S) -citronellol synthesis
CN111394292B (en) Multi-way composite neuraminic acid-producing bacillus subtilis and application thereof
CN111172127A (en) Application of sucrose phosphorylase in preparation of glycerol glucoside
CN111690624A (en) Method for synthesizing 2-O-alpha-D-glycerol glucoside by using microorganisms
CN113337495B (en) Method for improving sialic acid yield and application
CN111411066B (en) Double-way composite neuraminic acid-producing bacillus subtilis and construction method thereof
CN114317476B (en) Biocatalysis production process of glucosyl glycerine and sucrose phosphorylase thereof
CN111455003A (en) Method for preparing D-psicose from microalgae
CN114231509B (en) Sucrose phosphorylase and glucosyl glycerol production process
CN114395542B (en) Sucrose phosphorylase and application thereof
CN114250207B (en) High-activity sucrose phosphorylase and application thereof
CN113151378B (en) Method for preparing nucleoside, nicotinic acid adenine dinucleotide and nicotinic acid mononucleotide of nicotinic acid or derivative thereof, enzyme composition and application
CN111534498B (en) Cyclodextrin glucosyltransferase mutant with improved disproportionation specific activity and AA-2G yield
CN114164192B (en) Sucrose phosphorylase and application thereof in preparation of glucose-1-phosphate
CN114317477B (en) Sucrose phosphorylase and glucose-1-phosphoric acid production process
CN107988131B (en) Method for high-yield production of α -ketone-gamma-methylthiobutyric acid
CN114058610B (en) High-activity sucrose isomerase and application thereof
CN113957065B (en) Sucrose isomerase with high conversion rate and application thereof
CN114134136B (en) Rapid preparation method of isomaltulose under high reaction concentration and sucrose isomerase thereof
CN112625993B (en) Preparation of alpha-ketoglutaric acid by microbial conversion method
CN114574534B (en) Method for producing alpha-arbutin by using ionic liquid-based biocatalysis system
CN112779235B (en) Method for synthesizing various flavonoid glycosides by biological catalysis
CN114875011B (en) AMP phosphotransferase mutant, coding gene thereof and application thereof in ATP synthesis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant